TH
MM
Dengue fever is a common disease in Thailand during the rainy season when the Aedes mosquito is abundant, which can be life-threatening. There is currently a dengue vaccine, Qdenga, that covers all 4 strains, helping to reduce the chance of infection and reduce the severity of the disease.
In this article, we will introduce you to the Qdenga vaccine, its importance in preventing dengue fever, and where to get vaccinated.
Information about dengue vaccine
- Dengue Vaccine
- How effective is the dengue vaccine?
- Dengue vaccine price
- Who should get vaccinated against dengue fever?
- Who cannot get the dengue vaccine?
- Dengue vaccine side effects
- How many injections of dengue vaccine are needed?
- Do I need to get the dengue vaccine every year?
- Where can I get a dengue vaccine?
Dengue Vaccine
QDenga Dengue Vaccine is a live attenuated vaccine that prevents dengue infection and reduces the severity of dengue fever , a common infectious disease that can be severe to life-threatening. Dengue fever is caused by the dengue virus , which is transmitted through the bite of mosquitoes (Aedes aegypti and Aedes albopictus species).
When the virus enters the body, the patient will have a high fever, chills, a rash, body aches, fatigue, loss of appetite, and later the virus will cause the platelets to drop abnormally, resulting in easy bleeding throughout the body and may have other complications from the disease itself, such as shock, pulmonary edema, hepatitis, and can be severe to the point of death.
“Dengue fever currently has no antibiotic that can directly kill the virus. Treatment is symptomatic treatment of the patient and can be prevented by avoiding mosquito bites and vaccination.”
How effective is the dengue vaccine?
QDenga dengue vaccine can prevent dengue infection by 80%, reduce hospitalization rate by 90% (reduce the severity of the disease)
Dengue vaccine price
Who should get vaccinated against dengue fever?
- Vaccinate children and adults aged 4 years to 60 years. The recommended age for vaccination against dengue fever.
- Both those who have and have not had dengue fever can be vaccinated.
- Injected into the general public , especially those with underlying diseases, children and the elderly.
- People who live in areas with lots of mosquitoes
Who cannot get the dengue vaccine?
- Have a history of severe allergic reaction to dengue vaccine.
- People who have underlying immune diseases or are receiving immunosuppressive or steroid medication should consult their doctor again.
- Patients with untreated HIV infection or with low white blood cell counts
- Pregnant and breastfeeding women
Dengue vaccine side effects
Common side effects of QDenga dengue vaccine include:
- Pain, swelling, and redness at the injection site
- Headache, muscle aches
- Fatigue and fever
Symptoms occur within 2 days after injection. Symptoms are usually mild and not dangerous. and can heal on its own in 1-3 days And the side effects will be less. When the next injection is given  |
How many injections of dengue vaccine are needed?
QDenga dengue vaccine is administered as 2 injections, 3 months apart (at 0 and 3 months) by injecting subcutaneously in the upper arm.
Do I need to get the dengue vaccine every year?
Currently, QDenga Dengue Vaccine does not require a booster shot once two doses have been completed.
Where can I get a dengue vaccine?
Get vaccinated against dengue fever at a clinic near your home. Hospitals or medical facilities that provide vaccination services. Contact the clinic near your home in advance to check information on services, prices, and conditions.
In addition, there may be private hospitals that have special promotions for vaccination at special prices during certain periods.
|
|
Doctor’s advice
“QDenga Dengue Vaccine is an effective dengue vaccine with few side effects and relatively few limitations. It does not require an immunity test before vaccination, so it is useful and recommended for general patients.
Since dengue fever is a disease that can cause severe complications in patients of all ages and there is no direct antiviral drug, vaccination is very useful for this disease.”
-Dr. Natthawadi Sriburisut
Advice from the clinic’s doctor –
Reference documents
- QDENGA. Summary of product characteristics. European Medicines Agency (https:// www.ema.europa.eu/en/medicines/human/EPAR/qdenga, accessed April 2024)
- WHO position paper on dengue vaccines – May 2024
- Tricou V et al. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK- 003): 4·5-year results from a phase 3, randomized, double-blind, placebo-controlled trial. Lancet Glob Health. 2024; 12(2):e257–e270. doi:10.1016/S2214- 109X(23)00522-3.
Hot Line 
Nattawadee Sriborisut ,M.D.
General Practitioner
Last modified: 02/12/2024
Images may be used without prior permission exclusively for educational or informational purposes, as long as proper credit is given to intouchmedicare.com
Auto translator